What is People Science?
People Science operates as a specialized clinical research organization (CRO) that bridges the gap between consumer health products and scientific validation. Through its proprietary platform, Chloe, the company facilitates decentralized trials, enabling wellness brands to conduct exploratory studies and gold-standard clinical research with greater efficiency. By integrating mobile-first participant engagement with secure, real-world data collection, People Science provides a scalable infrastructure that enhances the credibility of health-focused consumer goods. The company's market position is defined by its ability to democratize access to clinical data, ensuring that wellness products are backed by robust, privacy-compliant evidence that meets modern regulatory and consumer expectations.
How much funding has People Science raised?
People Science has raised a total of $5.3M across 1 funding round:
Angel/Seed
$5.3M
Angel/Seed (2023): $5.3M with participation from Acre Venture Partners and Thia Ventures
Key Investors in People Science
Acre Venture Partners
Acre Venture Partners focuses on transformative investments in food and agriculture, prioritizing companies that address human and environmental health through sustainable technology.
Thia Ventures
Thia Ventures is a specialized fund management firm operating at the intersection of food, biotechnology, and health, providing strategic capital to innovative startups.
What's next for People Science?
With this major strategic investment, People Science is poised to scale its operational capacity and expand its footprint within the health-tech ecosystem. The company is expected to focus on enhancing the Chloe platform's analytical capabilities, potentially integrating advanced machine learning to derive deeper insights from real-world health data. As the wellness industry faces increasing scrutiny regarding product efficacy, People Science's role as a neutral, data-driven intermediary will likely become a critical component of the sector's maturation. Future growth will likely involve strategic partnerships with larger health conglomerates and the expansion of its research methodologies to accommodate a broader range of therapeutic and wellness-oriented applications.
See full People Science company page
